Dextenza intraocular and Pneumococcal Conjugate Vaccine (13-Valent)
Determining the interaction of Dextenza intraocular and Pneumococcal Conjugate Vaccine (13-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza intraocular-Pneumococcal Conjugate Vaccine (7-Valent)
- Dextenza intraocular-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Dextenza intraocular-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Dextenza intraocular-Pneumovax 23
- Dextenza intraocular-PNV - Omega
- Dextenza intraocular-PNV Iron Polysaccharides, Folic Acid, DHA
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextran 40
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextran 70 6% in 5% Dextrose high molecular weight
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextran 75
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextran high molecular weight
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextranomer and Hyaluronate Derivatives (Deflux)
- Pneumococcal Conjugate Vaccine (13-Valent)-Dextranomer and Hyaluronate Derivatives (Solesta)